About Geok Kim Corp
Our organization was founded with a deep sense of purpose — to honor the memory of Geok Kim Low, the beloved spouse of our founder, who sadly lost her battle with cancer. Her courage and strength continue to inspire us every day.
We established this non-profit to support the scientific community and accelerate research by providing affordable, high-quality laboratory products and services. Our mission is simple: help laboratories reduce costs without compromising results, so more resources can be directed toward groundbreaking discoveries and life-saving innovations.
Through this work, we hope to contribute to a future where science thrives and lives are saved — a future Geok passionately believed in.
About Our Team
We are a team of seasoned biotechnology professionals with decades of hands-on experience at the bench. Our collective background spans molecular biology, cell biology, drug discovery, virology, epigenetics, and next-generation sequencing. Over the years, we have successfully led and completed diverse research projects across both academic and industry settings.
Our mission is to support fellow scientists by offering high-quality, affordable laboratory tools that streamline workflows and meet the real-world demands of research environments.
Areas of Expertise
Molecular Biology
Construction of vectors and expression constructs
Cloning using restriction enzymes, Gibson assembly, TOPO, and Gateway systems
Cell Biology
Generation of stable cell lines with selection markers and clone isolation
Next Generation Sequencing (NGS)
Experience in preparing and optimizing sequencing workflows for various applications
Epigenetics
Execution of advanced epigenetic assays including ATAC-seq, RRBS, and CUT&Tag
Drug Discovery
Screening of compound libraries (including a 33,000-compound screen)
Structure-activity relationship (SAR) and mechanism of action studies
Virology
Viral stock production, purification, and titration
Development of ELISA and immunocytochemistry assays to study viral infections and antiviral mechanisms
